west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "梁力建" 22 results
  • Effect of Tie-2-siRNA Expression Vector on Human Hepatoma Transplanted Subcutaneously in Nude Mice

    Objective To explore the effect of Tie-2 small interference RNA (siRNA) treatment in human hepatoma transplanted subcutaneously in nude mice. Methods Tumor cells were implanted in the hind flank of male nude mice of 6 weeks. Tumor-bearing mice were divided into two groups (gene therapy group and control group) and injected intra-tumorally with Tie-2-siRNA/Lipofectamine and saline/Lipofectamine respectively. The tumor volume and weight, serum AFP and microvessel density (MVD) and the histological change of the tumor were tested after gene therapy. Results The growth inhibitory rates in gene therapy group were 26.94%, 53.01% and 68.91% on day 4, 7 and 10 after gene therapy respectively. The tumor volumes of gene therapy group (118.47, 111.57 and 104.59 mm3) were smaller than those of the control group (162.17, 237.46 and 336.41 mm3) respectively (P<0.01), and the weight of tumor in gene therapy group was lighter than that of the control group 〔(0.89±0.09) g vs (1.24±0.03), P<0.01〕. The AFP value in gene therapy group was obviously lower than that of the control group 〔(107.66±24.13) ng/ml vs (266.08±50.96) ng/ml, P<0.01〕. There was significant diference of MVD between the gene therapy group (34.63±4.07) and the control group (81.01±9.44) with the method of immunohistochemitry (P<0.01). Histopathology in the control group showed that the tumor volumes were bigger, and a high atypic of tumor cells were seen. The main pathological changes in tumor tissue of gene therapy group were necrosis, there were massive necrosis. The apoptosis cells were seen in the both of necrosis and non-necrosis areas in only 2 mice of gene therapy group. Conclusion Tie-2-siRNA inhibits the tumor growth and tumor angiogenesis, and is a possible new approach for liver neoplasm gene therapy.

    Release date:2016-09-08 11:49 Export PDF Favorites Scan
  • Prevention and Treatment of Perioperative Complications for Cholangiocarcinoma

    Release date:2016-09-08 11:54 Export PDF Favorites Scan
  • 胆囊癌的诊治进展

    Release date:2016-08-29 09:18 Export PDF Favorites Scan
  • The Evaluation and Rational Choice of Imaging Diagnostic Methods for Hepatolithiasis

    Release date:2016-09-08 11:53 Export PDF Favorites Scan
  • Protection of Liver function with Protease Inhibitor from IschemiaReperfusion Injury in Hepatocellular Carcinoma Patients Undergoing Hepatectomy after Hepatic Inflow Occlusion

    Objective To investigate whether protease inhibitor (ulinastatin, UTI) can protect liver from ischemiareperfusion injury in hepatocellular carcinoma (HCC) patients undergoing hepatectomy after hepatic inflow occlusion. Methods A prospective randomized control study was designed. Thirtyone HCC patients undergoing hepatectomy after hepatic inflow blood occlusion were randomly divided into the following two groups. UTI group (n=16), 1×105 units of ulinastatin was given intravenously in operation, then the dosage was continuously used twice a day up to 5 days postoperatively. Control group (n=15), the patients received other liver protective drugs. Liver function, plasma C-reactive protein (CRP) and cortisol level were compared between these two groups. Results The postoperative liver function of the UTI group was significantly improved compared with the control group. For example, on the third postoperative day the aspartate transaminase (AST), alanine transaminase (ALT) and total bilirubin level in the UTI group were significantly lower than those in the control group, respectively (P<0.05). On the first postoperative day, the plasma CRP concentration in the UTI group was significantly lower than that in the control group(P<0.01). The plasma cortisol level in the control group markedly increased compared with the level before operation(P=0.046). However, there was no significant difference in the UTI group between before and after operation. Conclusion Ulinastatin can effectively protect liver from ischemia/reperfusion injury in HCC patients undergoing hepatectomy performed after hepatic inflow occlusion. Also, it can relieve the surgical stress for patients.

    Release date:2016-08-28 04:43 Export PDF Favorites Scan
  • The Treatment Strategies of Incidental Gallbladder Carcinoma after Laparoscopic Cholecystectomy

    Release date:2016-09-08 10:37 Export PDF Favorites Scan
  • Issues to Be Concerned in The Management of Hilar Cholangiocarcinoma

    肝门部胆管癌(hilar cholangiocarcinoma),又称Klaskin癌,是指起源于左右肝管、分叉部和肝总管上段胆管上皮的恶性肿瘤,约占胆管癌的60%~70%[1]。由于其临床表现隐匿,早期难以被发现。目前根治性手术是最有效的提高其生存率的治疗方式,随着肝门部胆管癌R0切除率的不断升高,5年生存率不断提高[2,3],但仍有不少问题有待于解决……

    Release date:2016-09-08 10:56 Export PDF Favorites Scan
  • Genistein Regulates bax Gene Expression and Induces Apoptosis in Hepatocellular Carcinoma HepG2 Cells

    【 Abstract 】 Objective To probe into the role of inositol 1, 4, 5-trisphosphate (IP3) and bax gene expression in apoptosis of HepG2 cells induced by genistein (Gen). Methods HepG2 cells were treated with different concentrations including 20, 40, 60 and 80 μ mol/L Gen as HepG2 cells cultured with 0 μmol/L Gen for 72 h was control; HepG2 cells were treated with 60 μmol/L Gen for 6, 12, 24, 48 and 72 h as HepG2 cells treated with 60 μmol/L Gen for 0 h was control. IP3 content, bax mRNA expression and apoptosis rate were assayed by IP3- [ 3H ] Birtrak assay, RT-PCR and flow cytometry, respectively. ResultsHepG2 cells incubated with each concentration of Gen for 72 h , IP3 content was lower than that of control 〔 (17.7 ± 1.3), (11.2 ± 0.9), (4.9 ± 0.5), (4.8 ± 0.3) pmol/106 cells vs (29.4 ± 0.5) pmol/106 cells 〕 , P < 0.01 ; bax mRNA expression (RI which was the gray degree multiply area of bax/the gray degree multiply area of β -actin) was higher than that of control (0.26 ± 0.02, 0.33 ± 0.05, 0.35 ± 0.06, 0.38 ± 0.05 vs 0.09 ± 0.01), P < 0.01 ; The apoptosis rate was higher than that of control 〔 (10.1 ± 0.9)%, (18.7 ± 1.6)%,   (28.7 ± 2.5)%, (27.9 ± 2.0)% vs (2.6 ± 0.1)% 〕 , P < 0.01. HepG2 cells were incubated with 60 μ mol/L Gen for 6, 12, 24, 48 and 72 h , IP3 content was lower than that of control 〔 (22.6 ± 0.9), (12.0 ± 1.4), (7.5 ± 0.8), (5.6 ± 0.5), (4.3 ± 0.6) pmol/106 cells vs (29.2 ± 0.6) pmol/106 cells 〕 , P < 0.01 ; bax mRNA expression was higher than that of control incubated with 60 μ mol/L Gen for above 12 h (0.25 ± 0.06, 0.29 ± 0.02, 0.30 ± 0.02, 0.35 ± 0.04 vs 0.09 ± 0.01), P < 0.01 ; The apoptosis rate in groups incubated with 60 μ mol/L Gen for 24, 48 and 72 h was significantly higher than that in control 〔 (7.4 ± 0.5)%, (20.5 ± 2.0)%, (30.7 ± 1.6)% vs (2.6 ± 0.1)% 〕 , P < 0.01. ConclusionGen induces apoptosis of HepG2 cells by reducing IP3 production and increasing bax gene expression.

    Release date:2016-09-08 11:45 Export PDF Favorites Scan
  • Effects of Recombinant Human Growth Hormone on Hypoalbuminemia in Cirrhotic Rats after Partial Hepatectomy

    【Abstract】ObjectiveTo investigate the effects of rhGH on hypoalbuminemia in cirrhotic rats after partial hepatectomy. MethodsThirty rats were randomly divided into normal control group (n=6), liver cirrhosis group (LC group, n=6), liver cirrhosis and hepatectomy group (LCH group,n=6), PN (parenteral nutrition) group (n=6, given PN after hepatectomy) and rhGH+PN group (n=6,given rhGH and PN after hepatectomy). Liver function and blood glucose were measured. The expression of ALB mRNA was detected by RTPCR. Liver Ki67 immunohistochemistry was studied. ResultsCompared with PN group, serum ALP was lower; serum ALB and blood glucose were higher in rhGH+PN group. The expression of hepatic ALB mRNA was higher, and hepatic Ki67 labeling index was higher as well in this group. ConclusionrhGH can improve hypoalbuminemia after partial hepatectomy in cirrhotic rats with partial hepatectomy.

    Release date:2016-09-08 11:53 Export PDF Favorites Scan
  • STUDIES ON HEPATIC ISCHEMIA REPERFUSION INJURY IN RAT CIRRHOTIC LIVER

    Objective To investigate the extent of hepatic ischemia reperfusion (HIR) injury in rat cirrhotic liver under different ischemic time,and find the time limit under which the rat with cirrhotic liver could tolerate. Methods At first,the cirrhosis of the rat were induced by carbon tetrachloride(CCl4)injected subcutaneously. Then these rats were randomly divided into four groups. Group A(n=6) was made by sham operation, group B, C, D(n=16) were respectively given 20, 30, 40min hepatic warm ischemia. The 7day survival rate, AST, ALT, TNF and liver, pulmonary pathology were observed. Results The 7-day survival rate was decreased with the increase of hepatic ischemic time. The survival rate of group B, C, D were respectively 100%, 60%, 40%. Between group C, D and group B there were significant differences(P<0.05). The level of AST and ALT in group D were (2 448.4±942.3)u/L and (1 189.0±403.4)u/L respectively, and those in group C were (2 185.1±1 732.9)u/L and (1 183.5±707.2)u/L respectively, which were higher than those in group B and A significantly(P<0.01). The level of TNF was increased significantly 4hr after reperfusion, as compared with that before operation 〔(0.177±0.139)u/ml〕, P<0.01. TNF of group B, C, D were (0.399±0.216)u/ml, (0.671±0.351)u/ml and (0.789±0.371)u/ml respectively. At the same time the level of TNF in group C, D was higher than that in group B, A significantly(P<0.01). Liver and lung pathology showed increased damage with increasing ischemia. Conclusion Hepatic injury is induced by HIR in rats with cirrhotic liver, and its severity increases with the increase of ischemic time. There is a certain hepatic ischemic time between 20min and 30min, which can be tolerated by the rats with cirrhotic liver. TNF may be used as an indicator,showing the degree of HIR injury and foreseeing the result of injury.

    Release date:2016-08-28 05:30 Export PDF Favorites Scan
3 pages Previous 1 2 3 Next

Format

Content